Zaman S - Search Results

1

Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy response.

Hajiran A, Chakiryan N, Aydin AM, Zemp L, Nguyen J, Laborde JM, Chahoud J, Spiess PE, Zaman S, Falasiri S, Fournier M, Teer JK, Dhillon J, McCarthy S, Moran-Segura C, Katende EN, Sexton WJ, Koomen JM, Mulé J, Kim Y, Manley B. Hajiran A, et al. Among authors: zaman s. Clin Exp Immunol. 2021 Apr;204(1):96-106. doi: 10.1111/cei.13567. Epub 2021 Feb 9. Clin Exp Immunol. 2021. PMID: 33346915 Free PMC article.

2

Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.

Chobrutskiy BI, Zaman S, Tong WL, Diviney A, Blanck G. Chobrutskiy BI, et al. Among authors: zaman s. J Neurooncol. 2018 Dec;140(3):697-704. doi: 10.1007/s11060-018-03001-1. Epub 2018 Oct 31. J Neurooncol. 2018. PMID: 30382482

3

Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma.

Chobrutskiy BI, Yeagley M, Tipping P, Zaman S, Diviney A, Patel DN, Falasiri S, Uversky VN, Blanck G. Chobrutskiy BI, et al. Among authors: zaman s. Oncogene. 2020 Feb;39(8):1773-1783. doi: 10.1038/s41388-019-1101-2. Epub 2019 Nov 18. Oncogene. 2020. PMID: 31740784

4

Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy.

Zaman S, Hajiran A, Coba GA, Robinson T, Madanayake TW, Segarra DT, Chobrutskiy BI, Boyle TA, Zhou JM, Kim Y, Mulé JJ, Teer JK, Manley BJ. Zaman S, et al. Eur Urol Focus. 2021 Mar;7(2):373-380. doi: 10.1016/j.euf.2019.12.001. Epub 2019 Dec 31. Eur Urol Focus. 2021. PMID: 31901438 Free PMC article.

5

TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.

Arndt MF, Koohestani DM, Chobrutskiy BI, Mihyu MM, Diaz M, Gozlan EC, Yeagley M, Zaman S, Roca AM, Blanck G. Arndt MF, et al. Among authors: zaman s. Hum Immunol. 2020 Dec;81(12):692-696. doi: 10.1016/j.humimm.2020.08.007. Epub 2020 Sep 16. Hum Immunol. 2020. PMID: 32950267

6

Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity.

Eakins RA, Chobrutskiy A, Teer JK, Patel DN, Hsiang M, Huda TI, Zaman S, Sexton WJ, Coppola D, Falasiri S, Blanck G, Chobrutskiy BI. Eakins RA, et al. Among authors: zaman s. Mol Immunol. 2022 Oct;150:58-66. doi: 10.1016/j.molimm.2022.08.001. Epub 2022 Aug 17. Mol Immunol. 2022. PMID: 35987136

7

MMP7 sensitivity of mutant ECM proteins: An indicator of melanoma survival rates and T-cell infiltration.

Zaman S, Chobrutskiy BI, Patel JS, Callahan BM, Tong WL, Mihyu MM, Blanck G. Zaman S, et al. Clin Biochem. 2019 Jan;63:85-91. doi: 10.1016/j.clinbiochem.2018.11.004. Epub 2018 Nov 8. Clin Biochem. 2019. PMID: 30414845

8

T-cell receptor-α CDR3 domain chemical features correlate with survival rates in bladder cancer.

Chobrutskiy BI, Zaman S, Diviney A, Mihyu MM, Blanck G. Chobrutskiy BI, et al. Among authors: zaman s. J Cancer Res Clin Oncol. 2019 Mar;145(3):615-623. doi: 10.1007/s00432-018-2815-1. Epub 2018 Dec 11. J Cancer Res Clin Oncol. 2019. PMID: 30539280

9

A scoring system for the electrostatic complementarities of T-cell receptors and cancer-mutant amino acids: multi-cancer analyses of associated survival rates.

Chobrutskiy BI, Yeagley M, Diviney A, Zaman S, Gozlan EC, Tipping P, Koohestani DM, Roca AM, Blanck G. Chobrutskiy BI, et al. Among authors: zaman s. Immunology. 2020 Apr;159(4):373-383. doi: 10.1111/imm.13165. Epub 2020 Jan 21. Immunology. 2020. PMID: 31821535 Free PMC article.

10

Antiviral T Cell Receptor Complementarity Determining Region-3 Sequences Are Associated with a Worse Cancer Outcome: A Pancancer Analysis.

Zaman S, Chobrutskiy BI, Patel JS, Diviney A, Tu YN, Tong WL, Gill T, Blanck G. Zaman S, et al. Viral Immunol. 2020 Jun;33(5):404-412. doi: 10.1089/vim.2019.0156. Epub 2020 Apr 21. Viral Immunol. 2020. PMID: 32315578

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,210 results

Search Page

Filters